📰 Timothyp Walbert News
Timothyp Walbert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Timothyp Walbert. Real-time updates on events, politics, business and more.
June 2, 2023
Horizon Therapeutics plc (NASDAQ: HZNP): IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR, OFFEREE
January 4, 2023
Horizon Therapeutics plc (NASDAQ: HZNP): IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR, OFFEREE
December 13, 2022
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (NASDAQ: HZNP): FORM 8.1(a) & (b) (Opening Position Disclosure) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1. KEY INFORMATION (a) Full name of discloser: Horizon Therapeutics plc (b) Owner or controller
December 12, 2022
Horizon Therapeutics plc (NASDAQ: HZNP): NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT
November 1, 2022
Date change for the Horizon Irish Open, The Horizon Irish Open will assume a new place on the DP World Tour’s International Schedule next season when it is contested from September 7-10, 2023.
September 28, 2022
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
August 21, 2022
Tcwp LLC purchased a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 390 shares of the biopharmaceutical company’s stock, valued at approximately $41,000. Several other hedge funds have also recently added to or reduced their stakes in HZNP. Nuveen Asset […]
May 30, 2022
Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. The firm currently has a $100.00 price target on the biopharmaceutical company’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 5.44% […]
May 25, 2022
Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) – Equities research analysts at SVB Leerink issued their Q2 2022 earnings per share (EPS) estimates for Horizon Therapeutics Public in a note issued to investors on Sunday, May 22nd. SVB Leerink analyst D. Risinger forecasts that the biopharmaceutical company will post earnings per share of $1.33 […]
May 21, 2022
Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) CEO Timothy P. Walbert sold 25,000 shares of the stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $90.00, for a total value of $2,250,000.00. Following the transaction, the chief executive officer now directly owns 460,549 shares […]